These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23407235)

  • 1. A new tool for monitoring isoniazid preventive therapy.
    Eisenhut M
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):424. PubMed ID: 23407235
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy?
    Lawn SD; Wood R
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):995-6. PubMed ID: 22762421
    [No Abstract]   [Full Text] [Related]  

  • 3. Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa.
    Bristow CC; Larson E; Vilakazi-Nhlapo AK; Wilson M; Klausner JD
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1020-2. PubMed ID: 22668595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.
    Granich R; Getahun H; Reid A; Raviglione M; De Cock KM
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):925-6. PubMed ID: 19723370
    [No Abstract]   [Full Text] [Related]  

  • 5. Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.
    Martinson NA; McLeod KE; Milovanovic M; Msandiwa R; Lebina L
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):1005. PubMed ID: 25199022
    [No Abstract]   [Full Text] [Related]  

  • 6. Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.
    Marx FM; Yaesoubi R; Menzies NA; Salomon JA; Bilinski A; Beyers N; Cohen T
    Lancet Glob Health; 2018 Apr; 6(4):e426-e435. PubMed ID: 29472018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis preventive therapy for HIV-infected persons in less developed countries.
    Kritski AL
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S76-81. PubMed ID: 10688154
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation.
    Eldred LJ; Churchyard G; Durovni B; Godfrey-Faussett P; Grant AD; Getahun H; Chaisson RE
    AIDS; 2010 Nov; 24 Suppl 5():S1-3. PubMed ID: 21079422
    [No Abstract]   [Full Text] [Related]  

  • 9. The benefits and risks of mathematical modelling in tuberculosis.
    Cox HS
    Int J Tuberc Lung Dis; 2014 May; 18(5):507. PubMed ID: 24903782
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventive therapy against tuberculosis in people living with HIV.
    Wkly Epidemiol Rec; 1999 Nov; 74(46):385-98. PubMed ID: 10611855
    [No Abstract]   [Full Text] [Related]  

  • 11. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.
    Teklay G; Teklu T; Legesse B; Tedla K; Klinkenberg E
    BMC Public Health; 2016 Aug; 16(1):840. PubMed ID: 27543096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
    Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
    Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid prophylaxis against tuberculosis in children.
    Zar HJ; Lombard C
    N Engl J Med; 2011 Oct; 365(16):1543; author reply 1543-4. PubMed ID: 22010924
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis screening and isoniazid preventive therapy implementation: a Brazilian experience.
    Swaminathan S; Chandrasekaran P
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):289-92. PubMed ID: 24455973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid prevention of HIV-associated tuberculosis.
    Rangaka MX; Wilkinson RJ
    Lancet Infect Dis; 2013 Oct; 13(10):825-7. PubMed ID: 23954451
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving tuberculosis control: an interdisciplinary approach.
    Lienhardt C; Rustomjee R
    Lancet; 2006 Mar; 367(9514):949-50. PubMed ID: 16546548
    [No Abstract]   [Full Text] [Related]  

  • 17. A trial of mass isoniazid preventive therapy for tuberculosis control.
    Richardson ET; Wood R
    N Engl J Med; 2014 Apr; 370(17):1661-2. PubMed ID: 24758628
    [No Abstract]   [Full Text] [Related]  

  • 18. A trial of mass isoniazid preventive therapy for tuberculosis control.
    Ukwaja KN; Abimbola S
    N Engl J Med; 2014 Apr; 370(17):1661. PubMed ID: 24758627
    [No Abstract]   [Full Text] [Related]  

  • 19. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics.
    Havlir DV; Getahun H; Sanne I; Nunn P
    JAMA; 2008 Jul; 300(4):423-30. PubMed ID: 18647985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis preventive treatment in people living with HIV-Is the glass half empty or half full?
    Oxlade O; Rochon H; Campbell JR; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003702. PubMed ID: 34520458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.